SIP sigma pharmaceuticals limited

ubs

  1. 11,457 Posts.
    lightbulb Created with Sketch. 93
    1254 [Dow Jones] STOCK CALL: UBS cuts Sigma (SIP.AU) FY08 profit forecast to A$86 million, EPS estimate by 13% to 11.1 cents, price target to A$2.16 from A$2.60; follows SIP cut in earnings forecast to A$88 million-A$93 million. "Though this implies modest 2H margin recovery, it also appears realistic and we see limited downside risk from here," UBS says in a client note. "...the outlook appears realistic and, if FY08 guidance is met, then SIP is trading well below market and intrinsic value. Longer term, '08 generic reforms remain a risk." Keeps buy rating. Last trade down 5.5 cents at A$1.38
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.